Control-IQ artificial pancreas system improves time in glucose range

A new artificial pancreas system, called Control-IQ, has helped people with type…

Man with double amputation proclaims new lease of life

A grandfather from North Tyneside who had both his legs amputated below…

The Midlands has the highest rates of diabetes in England

The Midlands is the region with the highest prevalence of diabetes in…

Oral semaglutide outperforms empagliflozin in battle of diabetes tablets

Oral semaglutide, a tablet-based GLP-1 receptor agonist drug, has performed stronger in…

Diabetes technology inventor wins GBP 2 million compensation

A 13-year legal battle over pioneering diabetes technology has concluded with a…

Dummy innovation to measure glucose levels in babies

An infant’s dummy fitted with a biosensor could be used to measure…

Could breastfeeding reduce the risk of type 2 diabetes?

Breastfeeding is associated with a 30% reduction in risk of a mother…

US approves Farxiga to reduce heart failure hospitalisation risk for people with type 2 diabetes

Dapagliflozin (Farxiga) has been approved in the US as a treatment to…

Earring-based diabetes system selected for Dyson design awards

An earring and inhaler form part of a continuous glucose monitoring (CGM)…

Nearly 30,000 people receive FreeStyle Libre

Almost 30,000 people with type 1 diabetes across England have received access…